<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Recent studies have suggested an association between <z:hpo ids='HP_0002149'>hyperuricemia</z:hpo> and adverse renal outcomes in nondiabetic populations </plain></SENT>
<SENT sid="1" pm="."><plain>Data on the relationship between <z:hpo ids='HP_0002149'>hyperuricemia</z:hpo> and the risk of incident <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">kidney disease</z:e> (CKD) in type 2 diabetic patients with <z:mpath ids='MPATH_458'>normal</z:mpath> or near-<z:mpath ids='MPATH_458'>normal</z:mpath> kidney function are lacking </plain></SENT>
<SENT sid="2" pm="."><plain>We determined whether baseline serum <z:chebi fb="3" ids="27226">uric acid</z:chebi> levels predict the subsequent development of CKD in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>RESEARCH DESIGN AND METHODS: We followed 1,449 type 2 diabetic patients with <z:mpath ids='MPATH_458'>normal</z:mpath> kidney function and without overt <z:hpo ids='HP_0000093'>proteinuria</z:hpo> for 5 years for the occurrence of incident CKD (defined as overt <z:hpo ids='HP_0000093'>proteinuria</z:hpo> or estimated glomerular filtration rate [eGFR] &lt;60 mL/min/1.73 m(2)) </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: During a 5-year follow-up period, 194 (13.4%) patients developed incident CKD </plain></SENT>
<SENT sid="5" pm="."><plain>The cumulative incidence of CKD was significantly greater in patients with <z:hpo ids='HP_0002149'>hyperuricemia</z:hpo> than in those without <z:hpo ids='HP_0002149'>hyperuricemia</z:hpo> (29.5 vs. 11.4%, P &lt; 0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>In univariate logistic regression analysis, the presence of <z:hpo ids='HP_0002149'>hyperuricemia</z:hpo> roughly doubled the risk of developing CKD (odds ratio [OR] 2.55 [95% CI 1.71-3.85], P &lt; 0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>After adjusting for age, sex, BMI, smoking status, <z:mp ids='MP_0002055'>diabetes</z:mp> duration, systolic blood pressure, <z:chebi fb="0" ids="35674">antihypertensive</z:chebi> treatment, insulin therapy, HbA(1c), eGFR, and <z:mp ids='MP_0002871'>albuminuria</z:mp>, <z:hpo ids='HP_0002149'>hyperuricemia</z:hpo> was associated with an increased risk of incident CKD (adjusted OR 2.10 [1.16-3.76], P &lt; 0.01) </plain></SENT>
<SENT sid="8" pm="."><plain>In continuous analyses, a 1-SD increment in the serum <z:chebi fb="3" ids="27226">uric acid</z:chebi> level was significantly associated with a 21% increased risk of CKD </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: In type 2 diabetic individuals with preserved kidney function, <z:hpo ids='HP_0002149'>hyperuricemia</z:hpo> seems to be an independent risk factor for the development of incident CKD </plain></SENT>
</text></document>